Skip to content
AlternativeMed

Weight-Loss Medications and Medical Care: An Educational Overview

Educational overview of prescription weight-loss medicines such as semaglutide and tirzepatide, other medical options, what trials found, risks, regain after stopping, and unapproved copies.

Content last updated . This page has not been medically reviewed.

Overview

This page is an educational overview of medical weight care. It does not tell you whether to use any treatment. Decisions about medicines belong with a prescriber who knows your health history. Evidence labels: established recommendation, promising but limited, mixed, insufficient evidence.

Who might be offered medicines

NIDDK says prescription weight management medicines are meant for people with health problems related to overweight or obesity. A health care professional may prescribe one for an adult with a BMI of 30 or greater, or a BMI of 27 or greater with weight-related problems such as high blood pressure or type 2 diabetes. [1] NHS says medicines are usually prescribed alongside diet and lifestyle advice and that support should be offered after you stop. [2] Medicines do not replace healthy eating and physical activity. [1] NIDDK says they are not for everyone with a high BMI and should never be taken only to improve how you look. [1]

How they work

NIDDK says some medicines help you feel less hungry or full sooner, and others make it harder to absorb fat from food. [1] The injectable GLP-1 (glucagon-like peptide-1) medicines, such as semaglutide and liraglutide, mimic a hormone that targets brain areas that regulate appetite and food intake; tirzepatide mimics two hormones, GIP and GLP-1. [1] NHS says semaglutide works for weight loss by reducing appetite and helping you feel fuller for longer. [3] The same medicine is sold under different brand names for type 2 diabetes and for weight management. [3]

What the research shows

QuestionWhat the source foundLabel
Semaglutide (2.4 mg weekly, plus lifestyle)In the STEP 1 trial of 1,961 adults with obesity or overweight with a weight-related condition and no diabetes, mean weight change at 68 weeks was -14.9% with semaglutide versus -2.4% with placebo. [4]Established (randomized trial)
TirzepatideIn the SURMOUNT-1 trial of 2,539 adults, mean weight change at 72 weeks ranged from -15.0% to -20.9% across doses versus -3.1% with placebo. [5]Established (randomized trial)
Medicines overallNIDDK says that after 1 year, adults taking medication as part of a lifestyle program lose on average 3% to 12% more of their starting weight than people in a lifestyle program without medication; results vary. [1]Established
After stoppingIn the STEP 1 extension, people regained two-thirds of their prior weight loss a year after stopping semaglutide and the lifestyle intervention. [6] NIDDK says you will probably regain some weight after stopping. [1]Established
MuscleIn a 2026 meta-analysis, lean mass made up 25% to 39% of total weight lost with GLP-1-type medicines and about 26% with lifestyle programs; lifestyle plus resistance training had a lower share, about 17.5%. [7]Promising (comparisons across trials)

These are average results from trials. Individual results vary, and trials often exclude people with certain conditions. NHS advises not stopping semaglutide suddenly. [3]

Safety and side effects

  • NHS lists common semaglutide side effects as nausea and vomiting, constipation, diarrhea, tiredness, injection site reactions and hair loss. [3]
  • Serious but rare effects NHS lists include allergic reaction (swollen throat or tongue, difficulty breathing), worsening diabetic retinopathy, inflamed pancreas (severe stomach or back pain that does not go away), low blood sugar and sudden loss of vision. [3] NHS advises calling NHS 111 in the UK if you think you may be having serious side effects. [3] In the US, if someone has a swollen throat or difficulty breathing, call 911.
  • NIDDK says some people on certain weight-loss medicines have reported suicidal thoughts or actions, and the FDA continues to look into whether the medicines cause this. [1] If you have such thoughts, call or text 988 in the US.
  • Do not use these medicines in pregnancy or when planning pregnancy; NHS says semaglutide is not used in pregnancy and should be stopped at least 2 months before trying to conceive. [3][1]
  • GLP-1-type medicines are not suitable for people with a personal or family history of medullary thyroid cancer or MEN 2, according to NIDDK. [1]
  • Do not combine weight-loss medicines with other weight-loss products unless a health care professional prescribes it. [1] See How interactions work.

Unapproved and compounded copies

The FDA warns that unapproved versions of semaglutide and tirzepatide do not undergo FDA review for safety, effectiveness and quality; it recommends compounded drugs be used only when medical needs cannot be met by an approved drug, and warns about dosing errors, fraudulent labels and mishandled storage. [8] Red flags include no prescription requirement and prices that seem too good to be true. [8]

Other medical care

  • Nutrition counseling: NIDDK says a health care professional may refer you to a registered dietitian or a specific program. [9]
  • Structured programs: NHS lists 1 to 1 coaching, cognitive behavioral therapy, group support and online classes. [2]
  • Metabolic and bariatric surgery: NHS says it may be offered at a BMI of 40 or over, or 35 or over with other conditions that could improve, with lower thresholds for some backgrounds; recovery is usually 3 to 4 weeks. [2] NIDDK says some groups recommend it at lower BMI if other conditions are present. [10]
  • Devices: Long-term risks and benefits are not yet known. [10]
  • Insurance: Some, but not all, US plans cover these medicines. [1]

When to get help

Talk to your clinician or pharmacist before starting, changing or stopping any weight-loss medicine, and if you have side effects. If you have eating-disorder symptoms, tell your prescriber; NIDDK says one medicine (naltrexone-bupropion) is not for people with anorexia or bulimia. [1] See Weight and metabolism safety, Overweight and obesity, and Medicines that can change weight.

Frequently asked questions

Do GLP-1 medicines work?

In large randomized trials, average weight loss was substantially greater than with placebo (STEP 1: -14.9% vs -2.4%). [4] Weight is regained after stopping. [6]

Will I regain weight if I stop?

NIDDK says you probably will regain some, and in one trial extension people regained about two-thirds of the lost weight a year after stopping. [1][6]

Are compounded versions safe?

The FDA says unapproved versions are not reviewed for safety, effectiveness or quality. [8]

Can children or teens use weight-loss medicines?

NIDDK says the FDA has approved some for adolescents aged 12 and older, and one for people aged 6 and older with specific rare genetic conditions; these decisions belong to a pediatric specialist. [1]

References

  1. NIDDK. Prescription medications to treat overweight and obesity. Read 2026-10-22 (page last reviewed June 2024).
  2. NHS. Overweight and obesity in adults. Read 2026-10-22.
  3. NHS. Semaglutide: a medicine to manage type 2 diabetes or treat obesity. Read 2026-10-22.
  4. Wilding JPH et al. Once-weekly semaglutide in adults with overweight or obesity. N Engl J Med 2021 (STEP 1). Read 2026-10-22.
  5. Jastreboff AM et al. Tirzepatide once weekly for the treatment of obesity. N Engl J Med 2022 (SURMOUNT-1). Read 2026-10-22.
  6. Wilding JPH et al. Weight regain and cardiometabolic effects after withdrawal of semaglutide: the STEP 1 trial extension. Diabetes Obes Metab 2022. Read 2026-10-22.
  7. Lean mass changes with incretin therapy versus lifestyle intervention: a systematic review and meta-analysis of randomised controlled trials. PubMed record. Diabetes Obes Metab 2026. Read 2026-10-22.
  8. US FDA. FDA's concerns with unapproved GLP-1 drugs used for weight loss. Read 2026-10-22.
  9. NIDDK. Choosing a safe and successful weight-loss program. Read 2026-10-22.
  10. NIDDK. Treatment for adult overweight and obesity. Read 2026-10-22 (page last reviewed May 2023).
Education, not medical advice. This page is for general information. It does not diagnose or treat any condition and is not a substitute for care from a qualified health professional. Natural does not automatically mean safe. Ask a clinician or pharmacist before changing your care, especially if you take medication, are pregnant or breastfeeding, or have a health condition.